Artificial Intelligence in Genomics Market to Reach $6.22 Billion by 2029 - Exclusive Report by Meticulous Research®

REDDING, Calif., Dec. 7, 2022 /PRNewswire/ -- According to a new market research report titled, 'Artificial Intelligence in Genomics Market by Offering (Software, Services), Functionality (Sequencing, Gene Editing), Application (Diagnostics, Precision Medicine, Drug Discovery and Development), Delivery Mode (On-premise, Cloud) and End User - Global Forecast to 2029, "  published by Meticulous Research^®, the global AI in genomics market is expected to reach $6.22 billion by 2029 at a CAGR of 42.8% during the forecast period 2022–2029.

Download Free Report Sample Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5345

The application of artificial intelligence (AI) or machine learning has been widely increasing in genomics studies, requiring production of complex and large amounts of data. The integration of AI has been used in the discovery of cell morphology and spatial organization, prediction of DNA regulatory regions, cancer diagnosis, and identification of associations between phenotypes and genotypes. Drug discovery and precision medicine are the areas in pharmaceuticals largely impacted by the integration of AI in genomics. To accelerate precision medicine, AI is being used to convert genomic data into actionable clinical information.

In addition to accelerated drug discovery and precision medicines, technological advancements in AI capabilities in genomics and rising funding for genomics studies are driving the global AI in genomics market. Additionally, improving infrastructure for AI and genomics research in emerging economies offers market growth opportunities. However, ambiguous regulatory guidelines for genomics software and poor security & storage of large volumes of genome sequencing data pose a challenge for the market.

The artificial intelligence in genomics market is segmented by offering (software, services), delivery mode (on-premises, cloud & web-based), functionality (genome sequencing, gene editing, other functionalities), application (drug discovery and development, precision medicine, diagnostics, and other applications), end user (pharmaceutical & biopharmaceutical companies, academic & research institutes, and other end users), and geography. The study also evaluates industry competitors and analyzes their market shares at global and regional levels.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5345

Based on offering, in 2022, the software segment is estimated to account for the largest share of the global AI in genomics market. Software is the set of data or programs and instructions used to operate specific tasks. AI genomic software plays an important role in drug discovery, precision medicine, and diagnostics. The market players offer AI in genomics software-as-a-service, license-based, or subscription-based, which generates more revenue due to repeat purchases. The prices of these software offerings are high compared to the prices of services. Thus, the revenue generated by software is more compared to the services.

Based on delivery mode, the cloud & web-based segment is estimated to register the highest CAGR during the forecast period. The cloud & web-based models provide easy accessibility and increased scalability at lower costs. Furthermore, using cloud-based models, researchers can securely store, process, explore, and share large genomic datasets.

Based on functionality, in 2022, the genome sequencing segment is estimated to account for the largest share of the global AI in genomics market. The increasing adoption of AI in genome sequencing studies and the growing implementation of COVID-19-related R&D are contributing to the large market share of this segment. For instance, in January 2022, a research initiative led by scientists at Stanford University (U.S.), NVIDIA Corporation (U.S.), Oxford Nanopore Technologies Limited (U.K.), Google (U.S.), University of California (U.S.), and Baylor College of Medicine (U.S.) entered the Guinness World Record for fastest DNA sequencing technique using AI. The researchers used AI for sequencing a human genome in 5 hours and 2 minutes to ultimately use the findings in the diagnosis of rare genetic diseases in an average of eight hours.

Based on application, in 2022, the drug discovery and development segment is estimated to account for the largest share of the global AI in genomics market. The growing adoption of AI algorithms for drug discovery and rising collaboration between pharmaceutical/biopharmaceutical companies and AI solutions provider companies are driving the market.

Quick Buy –      Artificial Intelligence in Genomics Market - Global Opportunity Analysis And Industry Forecast (2022-2029), Research Report: https://www.meticulousresearch.com/Checkout/54335299

Based on end user, in 2022, the pharmaceutical & biopharmaceutical companies segment is estimated to account for the largest share of the global AI in genomics market. The adoption of AI in genomics is relatively high in drug discovery and development and precision medicine compared to diagnostics or animal health. Pharmaceutical & biopharmaceutical companies use AI algorithms to speed up the process of drug discovery. Thus, pharmaceutical & biopharmaceutical companies are the highest revenue contributors to the market.

Based on geography, the artificial intelligence in genomics market is segmented into five major regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, with a further analysis of major countries in these regions. In 2022, North America is estimated to account for the largest share of the global AI in genomics market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The key factors contributing to the large market share of this segment are the availability of infrastructure for genomic research and AI, the presence of key players in this region, and increasing research initiatives in genomics.

Some of the key players operating in the AI in genomics market are Microsoft Corporation (U.S.), NVIDIA Corporation (U.S.), Deep Genomics Incorporated (Canada), Fabric Genomics, Inc. (U.S.), Data4Cure, Inc. (U.S.), Predictive Oncology Inc. (U.S.), Emedgene Technologies LTD (U.S.), Congenica Ltd. (U.K.), Tempus Labs, Inc. (U.S.), SOPHiA GENETICS SA (Switzerland), Illumina Inc. (U.S.), and BenevolentAI Limited. (U.K.).

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/ai-in-genomics-market-5345

Scope of the Report:

Artificial Intelligence in Genomics Market, by Offering

• Software
• Services

Artificial Intelligence in Genomics Market, by Delivery Mode

• On-premises
• Cloud & Web-based

Artificial Intelligence in Genomics Market, by Functionality

• Genome Sequencing
• Gene Editing
• Other Functionalities

Note: Other functionalities include pharmacogenomics and predictive gene testing.

Artificial Intelligence in Genomics Market, by Application

• Drug Discovery & Development
• Precision Medicine
• Diagnostics
• Other Applications

Note: Other applications include agriculture, pharmacology, and animal health.

Artificial Intelligence in Genomics Market, by End User

• Pharmaceutical & Biopharmaceutical Companies
• Academic & Research Institutes
• Other End Users

Note: Other end users include contract research organizations and agriculture companies.

Artificial Intelligence in Genomics Market, by Geography

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Rest of Europe (RoE)
• Asia-Pacific (APAC)
• China
• Japan
• India
• Rest of APAC (RoAPAC)
• Latin America
• Brazil
• Mexico
• Rest of Latin America (RoLATAM)
• Middle East & Africa

Download Free Report Sample Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5345

Related Reports:

Healthcare Artificial Intelligence Market by Product and Services (Software, Services), Technology (Machine Learning, NLP), Application (Medical Imaging, Precision Medicine, Patient Management), End User (Hospitals, Patients) - Global Forecast to 2027

https://www.meticulousresearch.com/product/healthcare-artificial-intelligence-market-4937

Artificial Intelligence in Cybersecurity Market by Technology (ML, NLP), Security (Endpoint, Cloud, Network), Application (DLP, UTM, IAM, Antivirus, IDP), Industry (Retail, Government, BFSI, IT, Healthcare), and Region - Global Forecasts to 2029

 https://www.meticulousresearch.com/product/artificial-intelligence-in-cybersecurity-market-5101 

Artificial Intelligence in Manufacturing Market By Component, Technology (ML, NLP, Computer Vision), Application (Predictive Maintenance Quality Management, Supply Chain, Production Planning), Industry Vertical, & Geography - Global Forecast to 2028

https://www.meticulousresearch.com/product/artificial-intelligence-in-manufacturing-market-4983 

Artificial Intelligence in Retail Market by Product, Application (Predictive Merchandizing, Programmatic Advertising), Technology (Machine Learning, Natural Language Processing), Deployment (Cloud, On-Premises), and Geography - Global Forecast to 2027

https://www.meticulousresearch.com/product/artificial-intelligence-in-retail-market-4979 

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact:

Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding, 
California, 96001, U.S.
USA: +1-646-781-8004
Europe: +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com 
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Content Source: https://www.meticulousresearch.com/pressrelease/571/artificial-intelligence-in-genomics-market-2029

Logo: https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg